(S (NP-SBJ (NP (NN Mutation)) (PP (IN of) (NP (NNS tyrosines) (CD (493 492)))) (PP (IN in) (NP (NP (DT the) (NN kinase) (NN domain)) (PP (IN of) (NP (NN ZAP-70)))))) (VP (VBZ affects) (NP (JJ multiple) (NN T-cell) (NN receptor) (NN signaling) (NNS pathways))) (. .))
(S (NP-SBJ-21 (DT The) (JJ protein-tyrosine) (NN kinase) (NN ZAP-70)) (VP (VBZ is) (VP (VBN implicated) (NP-22 (-NONE- *-21)) (, ,) (PP (RB together) (IN with) (NP (DT the) (NN Src) (NN kinase) (NN p56-LRB-lck-RRB-))) (, ,) (PP (IN in) (S (NP-SBJ (-NONE- *-22)) (VP (VBG controlling) (NP (NP (DT the) (JJ early) (NNS steps)) (PP (IN of) (NP (DT the) (NP (NP (NN T-cell) (NN antigen) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))) (NN signaling) (NN cascade))))))))) (. .))
(S (S (NP-SBJ (-NONE- *-23)) (VP (TO To) (VP (VB help) (S (NP-SBJ (-NONE- *)) (VP (VB elucidate) (ADVP (RBR further)) (NP (NP (DT the) (NN mechanism)) (SBAR (WHPP-24 (IN by) (WHNP (WDT which))) (S (NP-SBJ (NN ZAP-70)) (VP (VBZ regulates) (NP (DT these) (JJ initial) (NNS events)) (PP (-NONE- *T*-24))))))))))) (, ,) (NP-SBJ-23 (PRP we)) (VP (VBD used) (NP (DT a) (JJ dominant-negative) (NN mutant) (NN approach))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD overexpressed) (PP (IN in) (NP (DT the) (NN Jurkat) (NN T-cell) (NN line))) (NP (NP (NN ZAP-70)) (VP (VBN mutated) (NP (-NONE- *)) (PP (IN on) (NP (NP-COOD (NP (NN Tyr-492)) (CC and) (NP (NN Tyr-493))) (PP (IN in) (NP (NP (DT the) (JJ putative) (JJ regulatory) (NN loop)) (PP (IN of) (NP (PRP$ its) (NN kinase) (NN domain)))))))))) (. .))
(S (NP-SBJ-25 (DT This) (NN mutant)) (VP (VBD inhibited) (NP (NP (JJ TCR-induced) (NN activation)) (PP (IN of) (NP (NP (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))))) (PP (IN by) (S (NP-SBJ (-NONE- *-25)) (VP (VBG interfering) (PP (IN with) (NP-COOD (CC both) (NP (JJ intracellular) (NN calcium) (NN increase)) (CC and) (NP (NP (JJ Ras-regulated) (NN activation)) (PP (IN of) (NP (JJ extracellular) (JJ signal-regulated) (NNS kinases)))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP-SBJ-26 (NP (JJ TCR-induced) (NN phosphorylation)) (PP (IN of) (NP (NN pp36-38))) (, ,) (VP (VBN thought) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (ADVP (RB upstream) (PP (IN of) (NP (DT these) (NNS pathways)))))))) (, ,)) (VP (VBD was) (VP (VBN found) (S (NP-SBJ-27 (-NONE- *-26)) (VP (TO to) (VP (VB be) (VP (VBN reduced) (NP (-NONE- *-27)))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN overexpression)) (PP (IN of) (NP (JJ wild-type) (NN ZAP-70)))) (VP (VBD induced) (NP (NP (JJ constitutive) (NN activation)) (PP (IN of) (NP (NP (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells))))))) (. .))
(S (NP-SBJ-28 (NP (DT The) (NN ZAP-70) (NN mutant)) (VP (VBN studied) (NP (-NONE- *)) (ADVP (RB here)))) (VP-COOD (VP (MD could) (VP (VB be) (VP (VBN phosphorylated) (NP-29 (-NONE- *-28)) (PP (IN on) (NP (NN tyrosine))) (SBAR-TMP (WHADVP-32 (WRB when)) (S (NP-SBJ-30 (-NONE- *-29)) (VP (VBN associated) (NP (-NONE- *-30)) (PP (TO to) (NP (DT the) (NN TCR) (NN zeta) (NN chain))) (ADVP (-NONE- *T*-32)))))))) (CC and) (VP (VBD was) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-28)) (VP (TO to) (VP (VB bind) (NP (NN p56-LRB-lck-RRB-)))))))) (. .))
(S (NP-SBJ (DT This) (NN result)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP-SBJ-COOD (NP (NN Tyr-492)) (CC and) (NP (NN Tyr-493))) (VP (VBP are) (RB not) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NP (DT the) (ADJP (NN Src) (NN homology) (NN domain) (JJ 2-mediated)) (NN association)) (PP (IN of) (NP (NN p56-LRB-lck-RRB-))) (PP (IN with) (NP (NN ZAP-70)))))))))) (. .))
(S (NP-SBJ (PRP$ Our) (NNS data)) (VP (VBP are) (ADJP-PRD (RBS most) (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN model)) (SBAR (WHPP-33 (IN in) (WHNP (WDT which))) (S (NP-SBJ (NP (NN recruitment)) (PP (TO to) (NP (DT the) (NN TCR)))) (VP (VBZ allows) (PP (-NONE- *T*-33)) (NP (NP (NN ZAP-70) (NP-COOD (NP (NN autophosphorylation)) (CC and) (NP (NP (NN binding)) (PP (TO to) (NP (NN p56-LRB-lck-RRB-)))))) (, ,) (SBAR (WHNP-34 (WDT which)) (S (PP (IN in) (NP (NN turn))) (NP-SBJ (-NONE- *T*-34)) (VP (VBZ phosphorylates) (NP-COOD (NP (NN Tyr-492)) (CC (or and)) (NP (NN Tyr-493))) (PP (IN with) (NP (NP (JJ consequent) (NN up-regulation)) (PP (IN of) (NP (DT the) (NN ZAP-70) (NN kinase) (NN activity)))))))))))))))) (. .))
(S (NP-SBJ-35 (NN ZAP-70)) (VP (MD will) (ADVP-TMP (RB then)) (VP (VB be) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-35)) (VP (TO to) (ADVP (RB effectively)) (VP-COOD (VP (VB control) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (PRP$ its) (NNS substrates))))) (CC and) (VP (VB lead) (PP (TO to) (NP (NN gene) (NN activation)))))))))) (. .))
